非对称性听力损失的新分子遗传病因:常染色体显性LMX1A变异
对728例接受外显子测序的先证者进行分析,发现5个LMX1A相关DFNA7家系(约0.7%),鉴定出4个新发LMX1A杂合变异和1个已报道的新发错义变异;所有先证者及多数受累个体均表现为非对称性听力损失,功能实验显示突变蛋白反式激活效率显著降低,4个新变异按ACMG指南判为致病、可能致病或意义不明。
要点
- LMX1A相关DFNA7家系约占728例先证者的0.7%,呈常染色体显性遗传。
- 所有先证者及多数受累个体均表现为双耳非对称性听力损失,程度不一。
- 4个新LMX1A变异按ACMG指南判为致病、可能致病或意义不明,突变蛋白反式激活效率显著降低。
核心结论
- 作者首次提出LMX1A是常染色体显性非对称性听力损失的候选基因之一,并将文献报道的LMX1A致病变异数量翻倍,扩展了DFNA7的基因型谱。
研究设计与样本
- 对728例先证者的基因组DNA行外显子测序,纳入所有发现致病性LMX1A变异的先证者,鉴定出5个常染色体显性DFNA7家系(约0.7%),用Sanger测序进行共分离分析,受累个体接受病史、体格检查、影像学和听力学表型评估,并通过计算结构建模和荧光素酶报告基因实验对变异进行功能鉴定。
主要发现
- 在728例先证者中鉴定出4个与DFNA7相关的新LMX1A杂合变异(c.622C>T:p.Arg208*、c.719A>G:p.Gln240Arg、c.721G>A:p.Val241Met、c.887dup:p.Gln297Thrfs*41)和1个已报道的新发杂合错义变异(c.595A>G;p.Arg199Gly)。
- 所有先证者和多数受累个体均存在非对称性听力损失,但非对称程度不一。
- 结构建模显示两个错义变异p.Gln240Arg和p.Val241Met影响同源域保守残基,减弱LMX1A与DNA的相互作用;p.Arg208*导致翻译提前终止,破坏包括DNA结合同源域在内的LMX1A蛋白结构;p.Gln297Thrfs*41导致参与LIM2结构域相互作用的C端螺旋丢失。
- 与野生型蛋白相比,所有突变LMX1A蛋白的反式激活效率均显著降低,表明其启动下游靶基因转录的能力严重受损。
- 按美国医学遗传学与基因组学学会(ACMG)遗传性听力损失指南,4个新LMX1A变异分别判为致病(p.Arg208*和p.Gln297Thrfs*41)、可能致病(p.Val241Met)和意义不明变异(p.Gln240Arg)。
关键数值与推荐
- 5个LMX1A相关DFNA7家系约占728例先证者的0.7%。
- 4个新LMX1A变异按ACMG指南判为致病(p.Arg208*和p.Gln297Thrfs*41)、可能致病(p.Val241Met)和意义不明变异(p.Gln240Arg)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Sensorineural hearing loss is the most common sensory disorder in humans. Genetic analyses have greatly increased our understanding of the pathogenic mechanisms in play. Thus, characterization of audiologic phenotypes by the genetic etiology may aid elucidation of the etiologies of certain types of inherited hearing loss. Further, delineation of specific audiologic phenotypes based on the genetic etiology aids our understanding of some types of inherited hearing loss in terms of the prediction of clinical course, revelation of genotype-phenotype correlations, and application of appropriate audiologic rehabilitation. Here, we describe the interesting audiologic characteristics of LMX1A -associated deafness, which revealed significant asymmetry between two ears. METHODS: Among 728 probands of which genomic DNA went through exome sequencing regardless of any specific audiologic phenotypes, probands for which exome sequencing was performed and a causative LMX1A variant was found were all included. Five LMX1A -associated DFNA7 families (approximately 0.7%), the pedigrees of whom indicated autosomal-dominant hearing loss, were identified, and segregation was studied using Sanger sequencing. The affected individuals underwent comprehensive evaluations, including medical history reviews, physical examinations, imaging, and auditory phenotyping. We functionally characterized the novel LMX1A variants via computational structural modeling and luciferase reporter assays. RESULTS: Among 728 probands of which genomic DNA went through exome sequencing, we identified four novel LMX1A heterozygous variants related to DFNA7 (c.622C>T:p.Arg208*, c.719A>G:p.Gln240Arg, c.721G>A:p.Val241Met, and c.887dup:p.Gln297Thrfs*41) and one harboring a de novo heterozygous missense LMX1A variant (c.595A>G;p.Arg199Gly) previously reported. It is important to note that asymmetric hearing loss was identified in all probands and most affected individuals, although the extent of asymmetry varied. Structural modeling revealed that the two missense variants, p.Gln240Arg and p.Val241Met, affected conserved residues of the homeodomain, thus attenuating LMX1A-DNA interaction. In addition, Arg208*-induced premature termination of translation destroyed the structure of the LMX1A protein, including the DNA-binding homeodomain, and p.Gln297Thrfs*41 led to the loss of the C-terminal helix involved in LIM2 domain interaction. Compared with the wild-type protein, all mutant LMX1A proteins had significantly reduced transactivation efficiency, indicating that the ability to elicit transcription of the downstream target genes of LMX1A was severely compromised. Thus, in line with the American College of Medical Genetics and Genomics guideline specified to genetic hearing loss, the four novel LMX1A variants were identified as "pathogenic" (p.Arg208* and p.Gln297Thrfs*41), "likely pathogenic" (p.Val241Met), and as a "variant of uncertain significance'' (p.Gln240Arg). CONCLUSION: For the first time, we suggest that LMX1A is one of the candidate genes which, if altered, could be associated with dominantly inherited asymmetric hearing loss. We also expand the genotypic spectrum of disease-causing variants of LMX1A causing DFNA7 by doubling the number of LMX1A variants reported thus far in the literature.
引用
- Lee SY, Soon Yoo H, Hee Han J, et al. Novel Molecular Genetic Etiology of Asymmetric Hearing Loss: Autosomal-Dominant LMX1A Variants. Ear Hear. 2022. PMID: 35711095. doi:10.1097/AUD.0000000000001237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。